Clinical Study
Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study
Table 2
Values of individual parameters of glucose fluctuation in the two groups at the end of the follow-up.
| | Acarbose+ | Acarbose− | value |
| Insulin dose/d | 36.43 ± 17.16 | 37.5 ± 12.40 | 0.891 | 24 h mean blood glucose (mmol/L) | 8.2 ± 1.39 | 8.4 ± 1.64 | 0.711 | SD of the 24 h mean blood glucose | 2.34 ± 0.67 | 2.68 ± 1.26 | 0.384 | Hyperglycemic episodes | 3.11 ± 1.69 | 3.36 ± 2.17 | 0.739 | Hypoglycemic episodes | 2.09 ± 1.68 | 2.38 ± 1.81 | 0.892 | Hyperglycemic time duration % (>10 mmol/L) | 0.28 ± 0.25% | 0.28 ± 0.19% | 0.963 | Hypoglycemic time duration % (<3.9 mmol/L) | 0.05 ± 0.08% | 0.07 ± 0.12% | 0.629 |
|
|